当前位置：首页 > 文献互助 > 互助详情

Phenotypic Hit Identification and Optimization of Novel Pan-TEAD and Subtype-Selective Inhibitors复制

用户6X7Ch8WUQ_gI 20天前 33 10 已完结

1. 系统已在2025-11-19 20:06:58对应助文件进行删除

2. 如有需要请重新发布求助信息

注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规

DOI: https://doi.org/10.1021/acs.jmedchem.5c02602复制

文献链接: https://pubs.acs.org/doi/10.1021/acs.jmedchem.5c02602复制

其他信息:

出版社: American Chemical Society (ACS)
作者: Timo Heinrich; Alessia Gambardella; Daniel Schwarz; Carl Petersson; Jakub Gunera; Sakshi Garg; Richard Schneider; Marina Keil; Lisa Grimmeisen; Andrea Unzue Lopez; Heike Schilke; Thomas Weitzel; Christian Kolb; Patrizia Diehl; Benjamin Doerfel; Uwe Anlauf; Vivian Reither; Corinna Rettig; Beate Opelt; Andrea Delp; Nicole Wildner; Djordje Musil; Erik Friedrich; Lars Burgdorf; Thomas Fuchss; Lisa Albers; Pedro M. F. Sousa; Filipe Freire; Tiago M. Bandeiras; Dirk Wienke
全文下载地址: https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.5c02602

上一篇：Small Molecules Targeting the Transmembrane Domain

下一篇：Rational Design and Biological Evaluation of a Novel Polθ Polymerase Inhibitor for Synergistic Targeting of HR-Deficient Cancers

互助时间线

2025-11-12 20:08:50 [完结求助]

楼主确认了萌妹子666应助的文件是正确的, 求助状态变成 已完结

2025-11-12 20:06:58 [上传文件]

萌妹子666上传了文件(pdf 7.57 MB), 求助状态变成 待确认

2025-11-12 20:06:32 [发起求助]

最新发布的求助

Safety and Efficacy of Senolytic UBX1325 in Diabetic Macular Edema 8小时前
Discovery of a Potent c-MET Inhibitor for Non-Small Cell Lung Cancer Treatment by AI-Based and Docking-Based Virtual Screening 8小时前
Discovery and Structural Optimization of Novel 2-Aminopyrimidine Derivatives as Potent and Selective IKKβ Inhibitors for the Treatment of Colorectal Cancer 9小时前
Design, Synthesis and Biological Evaluation of Novel, Potent, Selective and Orally Available DGKα Inhibitors for the Treatment of Tumors 9小时前
Selective PROTAC-mediated degradation of SMARCA2 is efficacious in SMARCA4 mutant cancers 9小时前
SMARCA4-driven oncogenic enhancer and transcriptional reprogramming in non-small cell lung cancer 9小时前
Combination therapy with selective SMARCA2 (BRM) degraders for treatment of SMARCA4 (BRG1)-deficient cancers 9小时前
N-Heterocyclic carbenes as tunable ligands for catalytic metal surfaces 9小时前
Potent SMARCA2 targeted degraders induce genetic synthetic lethality in SMARCA4 deleted cancer 9小时前
SMARCA4 loss increases RNA Polymerase II pausing and elevates R-loops to inhibit BRCA1-mediated repair in ovarian cancer 9小时前
Loss of SMARCA4 Leads to an Impaired Hematopoiesis in Mice 9小时前
A hydrophobic FeMn@Si catalyst increases olefins from syngas by suppressing C1 by-products 9小时前

wispass工作室 Copyright © 蜀ICP备2024051606号-2 www.wispass.com